Reducing the risk of cardiovascular events

Combination therapy with rivaroxaban and aspirin successfully reduces the risk of cardiovascular events in patients who have coronary artery disease and/or peripheral artery disease.

MEDICAL OR VETERINARY SCIENCE; HYGIENE

Medicinal preparations containing organic active ingredients-Heterocyclic compounds-having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins-having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines-1,4-Oxazines, e.g. morpholine-not condensed and containing further heterocyclic rings, e.g. timolol

PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 

Medicinal preparations containing organic active ingredients-Salicylic acid; Derivatives thereof-having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid -by carboxylic acids, e.g. acetylsalicylic acid

Drugs for disorders of the cardiovascular system-for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

General

Analytics

Cases

Patent Assignments

Citations